Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $41.7200 (-2.09%) ($41.5000 - $43.3600) on Sun. Dec. 16, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.02% (three month average) | RSI | 64 | Latest Price | $41.7200(-2.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.7% a day on average for past five trading days. | Weekly Trend | ATRA advances 4.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting ATRA price | ATRA will decline at least -2.01% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.01% (StdDev 4.02%) | Hourly BBV | 0 () | Intraday Trend | -0.8% | | | |
|
5 Day Moving Average | $42.42(-1.65%) | 10 Day Moving Average | $41.53(0.46%) | 20 Day Moving Average | $39.77(4.9%) | To recent high | -4.1% | To recent low | 32% | Market Cap | $N/A | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |